Exelixis
- Market cap
- 14.48B
- P/E (TTM)i
- 18.38
- P/Bi
- 7.85
- EPSi
- 2.78
- Div yieldi
- 0.00%
- 52W posi
- 90%
Anonymous reader poll. Unscientific, not investment advice.
Exelixis ended the session at 58.44, up 0.19%. Its market capitalisation is about 14.48B, the #1156 most valuable US-listed company we track. The trailing P/E of 18.39 is 37% below its five-year average of 29.08. The 6 analysts covering the stock are, on balance, at Buy, targeting an average of 53.67 (-8%). Against a 52-week band of 33.76-61.14, the shares are currently 90% of the way up.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 19% of the universe, above its 200-day average.
- Signal has read BUY for 2 months.
- Its last 7 Buy calls have averaged +5% over the following quarter.
- Recent price momentum is +24.9% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 10.7% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation B-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 18.5x | Better than 52% |
| Forward P/E | 16.5x | Better than 54% |
| Price / Sales | 5.9x | Better than 22% |
| P/E vs own 5-yr range | 22nd pctl | Better than 79% |
Growth A
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 12.9% | Better than 73% |
| Net income CAGR (3Y) | 62.5% | Better than 93% |
| Free cash flow CAGR (3Y) | 55.6% | Better than 88% |
Profitability A+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 96.4% | Better than 99% |
| Operating margin | 38.5% | Better than 93% |
| Net margin | 33.7% | Better than 93% |
| Return on equity | 35.5% | Better than 83% |
| Return on invested capital | 30.4% | Better than 95% |
Momentum A
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 3.1% | Better than 63% |
| 6-month return | 33.8% | Better than 83% |
| 12-month return (ex latest month) | 47.5% | Better than 79% |
| Distance below 52-week high | 3.7% | Better than 93% |
Financial Health A
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 3.6x | Better than 87% |
| Debt to assets | 6.1% | Better than 84% |
| Interest coverage | 19.3x | Better than 78% |
| Free cash flow / net income | 107.9% | Better than 46% |
Analyst View D-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 50.0% | Better than 23% |
| Upside to average target | -8.8% | Better than 2% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 58.33
- Open
- 58.47
- Day range
- 57.88 - 59.27
- Avg price
- 58.64
- Volume
- 2.37M
- Turnover
- 139.25M
- Turnover ratei
- 1.11%
- Volume ratioi
- 1.08
- Amplitudei
- 2.37%
- 52-week rangei
- 33.76 - 61.14
Valuation
- P/Ei
- 21.02
- P/E (TTM)i
- 18.38
- P/Bi
- 7.85
- EPSi
- 2.78
- Book value / shi
- 7.44
- Net profit
- 688.83M
- Net assets
- 1.84B
Share structure
- Market cap
- 14.48B
- Float capi
- 12.48B
- Shares out
- 247.78M
- Float sharesi
- 213.60M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
4.4% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-38.21M net over the window
Short interest
- Shares short
- 26.40M
- % of floati
- 10.65%
- Days to coveri
- 12.38
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Exelixis (EXEL)?
Exelixis last traded at 58.44. The quote on this page refreshes every few seconds while US markets are open.
What is Exelixis's market cap?
About 14.48B.
What is the P/E ratio of Exelixis?
The trailing twelve-month P/E is 18.38, below its own 5-year average of 29.08 — toward the bottom of its historical range (21.63% percentile). See the Valuation tab for the full history.
Does Exelixis pay a dividend?
Exelixis does not currently pay a regular dividend.
Is Exelixis a buy according to analysts?
The consensus of 6 analysts is a Buy rating, with an average 12-month price target of 53.67, which implies 8.2% downside from the current price. This is not investment advice.
What is Exelixis's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Exelixis a B (Buy). Twelve-month momentum in the top 19% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 01:42:01 · For reference only, not investment advice and not tailored to your situation.